5-FU-based chemotherapy remains the gold standard of first-line treatment for colon cancer, which exerts its cytotoxicity on cancer cells via inhibition of thymidylate synthase (TS) and incorporation of its metabolites into DNA and RNA (Longley et al., 2003). This evidence concerns the gene TYMS and malignant colon neoplasm.